Lara H. Böhmer

Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)

Pieternella J. Lugtenburg, Peter de Nully Brown, Bronno van der Holt et al. · Journal of Clinical Oncology · 2020 · 86 citations · Full text

Medicine, Oncology, Pharmacotherapy +7

Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study

Mirian Brink, Frederik O. Meeuwes, Marjolein van der Poel et al. · Blood · 2022 · 70 citations · Full text

Medicine, Geriatric Medicine, Oncology +11

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial

Martine E.D. Chamuleau, Coreline N. Burggraaff, Marcel Nijland et al. · Haematologica · 2019 · 53 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma

Suzanne I.M. Neppelenbroek, Y.M. Geurts, Berthe M.P. Aleman et al. · Journal of Clinical Oncology · 2024 · 32 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Light Therapy for Cancer-Related Fatigue in (Non-)Hodgkin Lymphoma Survivors: Results of a Randomized Controlled Trial

Daniëlle E. J. Starreveld, Laurien Daniëls, Jacobien M. Kieffer et al. · Cancers · 2021 · 26 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +16